ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02594384
Brief Title: A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma (LAM-002A/NHL) (LAM-002A/NHL)

First Submitted : October 29, 2015
First Submitted that Met QC Criteria : October 30, 2015
First Posted : November 3, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 9, 2019
Last Update Posted : January 10, 2019